monodesmethylcitalopram has been researched along with Depression, Involutional in 5 studies
*Depression, Involutional: Form of depression in those MIDDLE AGE with feelings of ANXIETY. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baskak, B; Devrimci Ozguven, H; Ozdemir, H; Ozel-Kizil, ET; Suzen, HS; Uckun, Z | 1 |
| Bonati, M; Butera, R; Cotti Cottini, F; Eleftheriou, G; Farina, M | 1 |
| Burgoyne, KS; Cook, IA; Fava, M; Gilmer, WS; Greenwald, S; Howland, RH; Iosifescu, D; Jain, R; Leuchter, AF; Marangell, LB; McCracken, JT; Trivedi, MH; Zisook, S | 1 |
| Aitchison, KJ; Campbell, D; Craig, IW; Farmer, AE; Giovannini, C; Gray, J; Gunasinghe, C; Hauser, J; Huezo-Diaz, P; Ingelman-Sundberg, M; Maier, W; Marusic, A; McGuffin, P; Mendlewicz, J; Mors, O; Perez, J; Perroud, N; Rietschel, M; Sim, S; Smith, R; Spencer, EP; Uher, R; Virding, S | 1 |
| Ahlner, J; Bengtsson, F; Carlsson, B; Dahl, ML; Lundmark, J; Olsson, G; Reis, M; Wålinder, J | 1 |
2 trial(s) available for monodesmethylcitalopram and Depression, Involutional
| Article | Year |
|---|---|
CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP.
Topics: Adult; Aged; Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Biotransformation; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Genetic Association Studies; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; White People; Young Adult | 2012 |
Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting.
Topics: Adolescent; Citalopram; Confidence Intervals; Contraceptives, Oral; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Prospective Studies; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sex Factors; Smoking | 2002 |
3 other study(ies) available for monodesmethylcitalopram and Depression, Involutional
| Article | Year |
|---|---|
The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder.
Topics: Adult; Aged; Citalopram; Cytochrome P-450 CYP2C19; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic | 2015 |
Neonatal toxicity following maternal citalopram treatment.
Topics: Citalopram; Depressive Disorder, Major; Diagnosis, Differential; Female; Half-Life; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors | 2013 |
Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study.
Topics: Adolescent; Adult; Aged; Biomarkers; Citalopram; Depressive Disorder, Major; Electroencephalography; Female; Frontal Lobe; Humans; Male; Middle Aged; Predictive Value of Tests; Psychiatric Status Rating Scales; Receptors, Serotonin; ROC Curve; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2009 |